Loading…
Assessment of quality of life in thyroid cancer patients using the EORTC thyroid-specific questionnaire: a prospective cross-sectional study
Background Many studies on the quality of life (QoL) among the thyroid cancer survivors have shown conflicting results. This may be since many of these studies have not used thyroid cancer-specific questionnaires. Patients and methods In our study we have translated the EORTC THY-34, validated and s...
Saved in:
Published in: | European archives of oto-rhino-laryngology 2024-04, Vol.281 (4), p.1953-1960 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c298t-a8b7d2bb8b2c8125a9e671a4bd2e9f1755f27dc1863ebe6fbd71d93af37331363 |
container_end_page | 1960 |
container_issue | 4 |
container_start_page | 1953 |
container_title | European archives of oto-rhino-laryngology |
container_volume | 281 |
creator | Thiagarajan, Shivakumar Fatehi, Khuzema Menon, Nandini Sawant, Mahesh Pal, Ankita |
description | Background
Many studies on the quality of life (QoL) among the thyroid cancer survivors have shown conflicting results. This may be since many of these studies have not used thyroid cancer-specific questionnaires.
Patients and methods
In our study we have translated the EORTC THY-34, validated and served it in a cross-sectional study to the assess the QoL among thyroid cancer patients free of disease during their routine follow-up. Patients were categorized based on the duration from treatment completion, ATA risk stratification, treatment received, number of RAI sessions and thyroid function status during analysis.
Results
Overall, 220 thyroid cancer survivors were included in this study. In general, in the EORTC QLQ–C30, the global QoL of thyroid cancer patients were good with a mean score of 72.99. The highest score was that for social functioning (89.55). In the EORTC–THY34 all the patients in the cohort had relatively lower scores (on symptom scales). Overall, there was no difference in the QLQ–C30 and THY-34 QoL with respect to any of the categorization mentioned above. However, our thyroid cancer patients QoL scores were better and/or comparable to those in published literature and they were also better or comparable to the QoL of the general population those were available in literature.
Conclusions
There was no difference in the QoL scores based on various categories. To better understand the quality of life of these patients a prospective longitudinal study with baseline values and values at regular intervals might give us a better insight. |
doi_str_mv | 10.1007/s00405-024-08471-w |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2929131653</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2929131653</sourcerecordid><originalsourceid>FETCH-LOGICAL-c298t-a8b7d2bb8b2c8125a9e671a4bd2e9f1755f27dc1863ebe6fbd71d93af37331363</originalsourceid><addsrcrecordid>eNp9kc1O3DAUha0KVAboC7BAXrIx-C9x0h0a0RYJCQnB2nKca2qUcaa-SdG8Aw9dzwx0ycrXOt89OrqHkDPBLwXn5go517xiXGrGG20Ee_1CFkIrzbSR9QFZ8FYZprUxR-QY8YVzXulWfSVHqlG8MbVYkLdrREBcQZroGOif2Q1x2mzHIQagMdHp9yaPsafeJQ-Zrt0UC4x0xpieiwr05v7hcfnBMVyDjyH64gU4xTElFzN8p46u87gVp_gXqC8zMtz-xuQGitPcb07JYXADwrf394Q8_bh5XP5id_c_b5fXd8zLtpmYazrTy65rOukbISvXQm2E010voQ3CVFWQpveiqRV0UIeuN6JvlQvKKCVUrU7Ixd63JNqltKuIHobBJRhntLKVrVCirlRB5R7dBc4Q7DrHlcsbK7jdtmD3LdjSgt21YF_L0vm7_9ytoP-_8nH2Aqg9gEVKz5Dtyzjncgf8zPYf8mmWtA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2929131653</pqid></control><display><type>article</type><title>Assessment of quality of life in thyroid cancer patients using the EORTC thyroid-specific questionnaire: a prospective cross-sectional study</title><source>Springer Link</source><creator>Thiagarajan, Shivakumar ; Fatehi, Khuzema ; Menon, Nandini ; Sawant, Mahesh ; Pal, Ankita</creator><creatorcontrib>Thiagarajan, Shivakumar ; Fatehi, Khuzema ; Menon, Nandini ; Sawant, Mahesh ; Pal, Ankita</creatorcontrib><description>Background
Many studies on the quality of life (QoL) among the thyroid cancer survivors have shown conflicting results. This may be since many of these studies have not used thyroid cancer-specific questionnaires.
Patients and methods
In our study we have translated the EORTC THY-34, validated and served it in a cross-sectional study to the assess the QoL among thyroid cancer patients free of disease during their routine follow-up. Patients were categorized based on the duration from treatment completion, ATA risk stratification, treatment received, number of RAI sessions and thyroid function status during analysis.
Results
Overall, 220 thyroid cancer survivors were included in this study. In general, in the EORTC QLQ–C30, the global QoL of thyroid cancer patients were good with a mean score of 72.99. The highest score was that for social functioning (89.55). In the EORTC–THY34 all the patients in the cohort had relatively lower scores (on symptom scales). Overall, there was no difference in the QLQ–C30 and THY-34 QoL with respect to any of the categorization mentioned above. However, our thyroid cancer patients QoL scores were better and/or comparable to those in published literature and they were also better or comparable to the QoL of the general population those were available in literature.
Conclusions
There was no difference in the QoL scores based on various categories. To better understand the quality of life of these patients a prospective longitudinal study with baseline values and values at regular intervals might give us a better insight.</description><identifier>ISSN: 0937-4477</identifier><identifier>EISSN: 1434-4726</identifier><identifier>DOI: 10.1007/s00405-024-08471-w</identifier><identifier>PMID: 38308761</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Head and Neck ; Head and Neck Surgery ; Medicine ; Medicine & Public Health ; Neurosurgery ; Otorhinolaryngology</subject><ispartof>European archives of oto-rhino-laryngology, 2024-04, Vol.281 (4), p.1953-1960</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c298t-a8b7d2bb8b2c8125a9e671a4bd2e9f1755f27dc1863ebe6fbd71d93af37331363</cites><orcidid>0000-0003-1957-3338</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38308761$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thiagarajan, Shivakumar</creatorcontrib><creatorcontrib>Fatehi, Khuzema</creatorcontrib><creatorcontrib>Menon, Nandini</creatorcontrib><creatorcontrib>Sawant, Mahesh</creatorcontrib><creatorcontrib>Pal, Ankita</creatorcontrib><title>Assessment of quality of life in thyroid cancer patients using the EORTC thyroid-specific questionnaire: a prospective cross-sectional study</title><title>European archives of oto-rhino-laryngology</title><addtitle>Eur Arch Otorhinolaryngol</addtitle><addtitle>Eur Arch Otorhinolaryngol</addtitle><description>Background
Many studies on the quality of life (QoL) among the thyroid cancer survivors have shown conflicting results. This may be since many of these studies have not used thyroid cancer-specific questionnaires.
Patients and methods
In our study we have translated the EORTC THY-34, validated and served it in a cross-sectional study to the assess the QoL among thyroid cancer patients free of disease during their routine follow-up. Patients were categorized based on the duration from treatment completion, ATA risk stratification, treatment received, number of RAI sessions and thyroid function status during analysis.
Results
Overall, 220 thyroid cancer survivors were included in this study. In general, in the EORTC QLQ–C30, the global QoL of thyroid cancer patients were good with a mean score of 72.99. The highest score was that for social functioning (89.55). In the EORTC–THY34 all the patients in the cohort had relatively lower scores (on symptom scales). Overall, there was no difference in the QLQ–C30 and THY-34 QoL with respect to any of the categorization mentioned above. However, our thyroid cancer patients QoL scores were better and/or comparable to those in published literature and they were also better or comparable to the QoL of the general population those were available in literature.
Conclusions
There was no difference in the QoL scores based on various categories. To better understand the quality of life of these patients a prospective longitudinal study with baseline values and values at regular intervals might give us a better insight.</description><subject>Head and Neck</subject><subject>Head and Neck Surgery</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neurosurgery</subject><subject>Otorhinolaryngology</subject><issn>0937-4477</issn><issn>1434-4726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kc1O3DAUha0KVAboC7BAXrIx-C9x0h0a0RYJCQnB2nKca2qUcaa-SdG8Aw9dzwx0ycrXOt89OrqHkDPBLwXn5go517xiXGrGG20Ee_1CFkIrzbSR9QFZ8FYZprUxR-QY8YVzXulWfSVHqlG8MbVYkLdrREBcQZroGOif2Q1x2mzHIQagMdHp9yaPsafeJQ-Zrt0UC4x0xpieiwr05v7hcfnBMVyDjyH64gU4xTElFzN8p46u87gVp_gXqC8zMtz-xuQGitPcb07JYXADwrf394Q8_bh5XP5id_c_b5fXd8zLtpmYazrTy65rOukbISvXQm2E010voQ3CVFWQpveiqRV0UIeuN6JvlQvKKCVUrU7Ixd63JNqltKuIHobBJRhntLKVrVCirlRB5R7dBc4Q7DrHlcsbK7jdtmD3LdjSgt21YF_L0vm7_9ytoP-_8nH2Aqg9gEVKz5Dtyzjncgf8zPYf8mmWtA</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Thiagarajan, Shivakumar</creator><creator>Fatehi, Khuzema</creator><creator>Menon, Nandini</creator><creator>Sawant, Mahesh</creator><creator>Pal, Ankita</creator><general>Springer Berlin Heidelberg</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1957-3338</orcidid></search><sort><creationdate>20240401</creationdate><title>Assessment of quality of life in thyroid cancer patients using the EORTC thyroid-specific questionnaire: a prospective cross-sectional study</title><author>Thiagarajan, Shivakumar ; Fatehi, Khuzema ; Menon, Nandini ; Sawant, Mahesh ; Pal, Ankita</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c298t-a8b7d2bb8b2c8125a9e671a4bd2e9f1755f27dc1863ebe6fbd71d93af37331363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Head and Neck</topic><topic>Head and Neck Surgery</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neurosurgery</topic><topic>Otorhinolaryngology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thiagarajan, Shivakumar</creatorcontrib><creatorcontrib>Fatehi, Khuzema</creatorcontrib><creatorcontrib>Menon, Nandini</creatorcontrib><creatorcontrib>Sawant, Mahesh</creatorcontrib><creatorcontrib>Pal, Ankita</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European archives of oto-rhino-laryngology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thiagarajan, Shivakumar</au><au>Fatehi, Khuzema</au><au>Menon, Nandini</au><au>Sawant, Mahesh</au><au>Pal, Ankita</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of quality of life in thyroid cancer patients using the EORTC thyroid-specific questionnaire: a prospective cross-sectional study</atitle><jtitle>European archives of oto-rhino-laryngology</jtitle><stitle>Eur Arch Otorhinolaryngol</stitle><addtitle>Eur Arch Otorhinolaryngol</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>281</volume><issue>4</issue><spage>1953</spage><epage>1960</epage><pages>1953-1960</pages><issn>0937-4477</issn><eissn>1434-4726</eissn><abstract>Background
Many studies on the quality of life (QoL) among the thyroid cancer survivors have shown conflicting results. This may be since many of these studies have not used thyroid cancer-specific questionnaires.
Patients and methods
In our study we have translated the EORTC THY-34, validated and served it in a cross-sectional study to the assess the QoL among thyroid cancer patients free of disease during their routine follow-up. Patients were categorized based on the duration from treatment completion, ATA risk stratification, treatment received, number of RAI sessions and thyroid function status during analysis.
Results
Overall, 220 thyroid cancer survivors were included in this study. In general, in the EORTC QLQ–C30, the global QoL of thyroid cancer patients were good with a mean score of 72.99. The highest score was that for social functioning (89.55). In the EORTC–THY34 all the patients in the cohort had relatively lower scores (on symptom scales). Overall, there was no difference in the QLQ–C30 and THY-34 QoL with respect to any of the categorization mentioned above. However, our thyroid cancer patients QoL scores were better and/or comparable to those in published literature and they were also better or comparable to the QoL of the general population those were available in literature.
Conclusions
There was no difference in the QoL scores based on various categories. To better understand the quality of life of these patients a prospective longitudinal study with baseline values and values at regular intervals might give us a better insight.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>38308761</pmid><doi>10.1007/s00405-024-08471-w</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-1957-3338</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0937-4477 |
ispartof | European archives of oto-rhino-laryngology, 2024-04, Vol.281 (4), p.1953-1960 |
issn | 0937-4477 1434-4726 |
language | eng |
recordid | cdi_proquest_miscellaneous_2929131653 |
source | Springer Link |
subjects | Head and Neck Head and Neck Surgery Medicine Medicine & Public Health Neurosurgery Otorhinolaryngology |
title | Assessment of quality of life in thyroid cancer patients using the EORTC thyroid-specific questionnaire: a prospective cross-sectional study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T20%3A50%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20quality%20of%20life%20in%20thyroid%20cancer%20patients%20using%20the%20EORTC%20thyroid-specific%20questionnaire:%20a%20prospective%20cross-sectional%20study&rft.jtitle=European%20archives%20of%20oto-rhino-laryngology&rft.au=Thiagarajan,%20Shivakumar&rft.date=2024-04-01&rft.volume=281&rft.issue=4&rft.spage=1953&rft.epage=1960&rft.pages=1953-1960&rft.issn=0937-4477&rft.eissn=1434-4726&rft_id=info:doi/10.1007/s00405-024-08471-w&rft_dat=%3Cproquest_cross%3E2929131653%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c298t-a8b7d2bb8b2c8125a9e671a4bd2e9f1755f27dc1863ebe6fbd71d93af37331363%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2929131653&rft_id=info:pmid/38308761&rfr_iscdi=true |